Stockreport

UPDATE 2-Biotech company CureVac aims to raise up to $245 mln in U.S. IPO [Reuters]

GSK plc American Depositary Shares (Each representing two Ordinary Shares)  (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors
PDF CureVac aims to raise up to $245 million in U.S. IPO FRANKFURT (Reuters) - CureVac, one of Germany’s leading contenders to develop a COVID-19 vaccine, said it aims to ra [Read more]